Stock Events

Regeneron Pharmaceuticals (REGN) Q3 2021 Earnings

5AugConfirmed
Q4 2020
Q1 2021
Q2 2021
Q3 2021
7.32
13.48
19.64
25.8

Details

Expected EPS
18.83
Actual EPS
25.8
Surprise EPS
6.97
Surprise Percent
+37.02%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 25.8 per share for Q3 2021.

0 Comments

Share your thoughts